109 related articles for article (PubMed ID: 9806548)
1. The Fanconi anaemia group G gene FANCG is identical with XRCC9.
de Winter JP; Waisfisz Q; Rooimans MA; van Berkel CG; Bosnoyan-Collins L; Alon N; Carreau M; Bender O; Demuth I; Schindler D; Pronk JC; Arwert F; Hoehn H; Digweed M; Buchwald M; Joenje H
Nat Genet; 1998 Nov; 20(3):281-3. PubMed ID: 9806548
[TBL] [Abstract][Full Text] [Related]
2. Complementation analysis in Fanconi anemia: assignment of the reference FA-H patient to group A.
Joenje H; Levitus M; Waisfisz Q; D'Andrea A; Garcia-Higuera I; Pearson T; van Berkel CG; Rooimans MA; Morgan N; Mathew CG; Arwert F
Am J Hum Genet; 2000 Sep; 67(3):759-62. PubMed ID: 10936108
[TBL] [Abstract][Full Text] [Related]
3. Endocrine profiling in patients with Fanconi anemia, homozygous for a FANCG founder mutation.
Dillon B; Feben C; Segal D; du Plessis J; Reynders D; Wainwright R; Poole J; Krause A
Mol Genet Genomic Med; 2020 Aug; 8(8):e1351. PubMed ID: 32529760
[TBL] [Abstract][Full Text] [Related]
4. Molecular and genealogical evidence for a founder effect in Fanconi anemia families of the Afrikaner population of South Africa.
Tipping AJ; Pearson T; Morgan NV; Gibson RA; Kuyt LP; Havenga C; Gluckman E; Joenje H; de Ravel T; Jansen S; Mathew CG
Proc Natl Acad Sci U S A; 2001 May; 98(10):5734-9. PubMed ID: 11344308
[TBL] [Abstract][Full Text] [Related]
5. Identification of a Hypomorphic
Meek K; Yang YT; Takada M; Parys M; Richter M; Engleberg AI; Thaiwong T; Griffin RL; Schall PZ; Kramer AJ; Yuzbasiyan-Gurkan V
Genes (Basel); 2022 Sep; 13(10):. PubMed ID: 36292578
[TBL] [Abstract][Full Text] [Related]
6. A strategy for molecular diagnostics of Fanconi anemia in Brazilian patients.
Pilonetto DV; Pereira NF; Bonfim CMS; Ribeiro LL; Bitencourt MA; Kerkhoven L; Floor K; Ameziane N; Joenje H; Gille JJP; Pasquini R
Mol Genet Genomic Med; 2017 Jul; 5(4):360-372. PubMed ID: 28717661
[TBL] [Abstract][Full Text] [Related]
7. Oligogenic basis of premature ovarian insufficiency: an observational study.
Long P; Wang L; Tan H; Quan R; Hu Z; Zeng M; Deng Z; Huang H; Greenbaum J; Deng H; Xiao H
J Ovarian Res; 2024 Feb; 17(1):32. PubMed ID: 38310280
[TBL] [Abstract][Full Text] [Related]
8. NTHL1 is a recessive cancer susceptibility gene.
Nurmi AK; Pelttari LM; Kiiski JI; Khan S; Nurmikolu M; Suvanto M; Aho N; Tasmuth T; Kalso E; Schleutker J; Kallioniemi A; Heikkilä P; ; Aittomäki K; Blomqvist C; Nevanlinna H
Sci Rep; 2023 Nov; 13(1):21127. PubMed ID: 38036545
[TBL] [Abstract][Full Text] [Related]
9. A C57BL/6J Fancg-KO Mouse Model Generated by CRISPR/Cas9 Partially Captures the Human Phenotype.
Shah R; van den Berk PCM; Pritchard CEJ; Song JY; Kreft M; Pilzecker B; Jacobs H
Int J Mol Sci; 2023 Jul; 24(13):. PubMed ID: 37446306
[TBL] [Abstract][Full Text] [Related]
10. Inherited bone marrow failure in the pediatric patient.
Dokal I; Tummala H; Vulliamy T
Blood; 2022 Aug; 140(6):556-570. PubMed ID: 35605178
[TBL] [Abstract][Full Text] [Related]
11. Fanconi Anemia: A Syndrome of Anemia and Skeletal Malformations Progressing to a Gene Network Involved in Genomic Stability and Malignant Disease.
Poot M
Mol Syndromol; 2020 Nov; 11(4):178-182. PubMed ID: 33224011
[No Abstract] [Full Text] [Related]
12. Recent advances in understanding hematopoiesis in Fanconi Anemia.
Bagby G
F1000Res; 2018; 7():105. PubMed ID: 29399332
[TBL] [Abstract][Full Text] [Related]
13. A never-ending story: the steadily growing family of the FA and FA-like genes.
Gueiderikh A; Rosselli F; Neto JBC
Genet Mol Biol; 2017; 40(2):398-407. PubMed ID: 28558075
[TBL] [Abstract][Full Text] [Related]
14. Recent discoveries in the molecular pathogenesis of the inherited bone marrow failure syndrome Fanconi anemia.
Mamrak NE; Shimamura A; Howlett NG
Blood Rev; 2017 May; 31(3):93-99. PubMed ID: 27760710
[TBL] [Abstract][Full Text] [Related]
15. Metformin improves defective hematopoiesis and delays tumor formation in Fanconi anemia mice.
Zhang QS; Tang W; Deater M; Phan N; Marcogliese AN; Li H; Al-Dhalimy M; Major A; Olson S; Monnat RJ; Grompe M
Blood; 2016 Dec; 128(24):2774-2784. PubMed ID: 27756748
[TBL] [Abstract][Full Text] [Related]
16. Mechanisms of interstrand DNA crosslink repair and human disorders.
Hashimoto S; Anai H; Hanada K
Genes Environ; 2016; 38():9. PubMed ID: 27350828
[TBL] [Abstract][Full Text] [Related]
17. Update of the human and mouse Fanconi anemia genes.
Dong H; Nebert DW; Bruford EA; Thompson DC; Joenje H; Vasiliou V
Hum Genomics; 2015 Nov; 9():32. PubMed ID: 26596371
[TBL] [Abstract][Full Text] [Related]
18. AluY-mediated germline deletion, duplication and somatic stem cell reversion in UBE2T defines a new subtype of Fanconi anemia.
Virts EL; Jankowska A; Mackay C; Glaas MF; Wiek C; Kelich SL; Lottmann N; Kennedy FM; Marchal C; Lehnert E; Scharf RE; Dufour C; Lanciotti M; Farruggia P; Santoro A; Savasan S; Scheckenbach K; Schipper J; Wagenmann M; Lewis T; Leffak M; Farlow JL; Foroud TM; Honisch E; Niederacher D; Chakraborty SC; Vance GH; Pruss D; Timms KM; Lanchbury JS; Alpi AF; Hanenberg H
Hum Mol Genet; 2015 Sep; 24(18):5093-108. PubMed ID: 26085575
[TBL] [Abstract][Full Text] [Related]
19. Coregulation of FANCA and BRCA1 in human cells.
Haitjema A; Mol BM; Kooi IE; Massink MP; Jørgensen JA; Rockx DA; Rooimans MA; de Winter JP; Meijers-Heijboer H; Joenje H; Dorsman JC
Springerplus; 2014; 3():381. PubMed ID: 25161863
[TBL] [Abstract][Full Text] [Related]
20. PALB2: the hub of a network of tumor suppressors involved in DNA damage responses.
Park JY; Zhang F; Andreassen PR
Biochim Biophys Acta; 2014 Aug; 1846(1):263-75. PubMed ID: 24998779
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
